Previous 10 | Next 10 |
home / stock / ipcif / ipcif news
TORONTO, ON / ACCESSWIRE / October 15, 2021 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targete...
TORONTO, ON / ACCESSWIRE / April 22, 2021 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targete...
TORONTO, ON / ACCESSWIRE / March 1, 2021 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-r...
TORONTO, ON / ACCESSWIRE / December 15, 2020 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-re...
TORONTO, ON / ACCESSWIRE / October 15, 2020 / Intellipharmaceutics International Inc. (OTCQB IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-...
NEW YORK , Aug. 17, 2020 /PRNewswire/ -- UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK SUMMARY NOTICE OF PROPOSED SETTLEMENT TO: ALL PERSONS WHO purchased INTELLIPHARMACEUTICS COMMON STOCK (trading symbol IPCI) IN COVERED TRANSACTIONS between May 21, 2015 ...
Intellipharmaceutics International ( OTC:IPCIF ) : Q2 GAAP EPS of -$0.04. More news on: Intellipharmaceutics International Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
TORONTO, ON / ACCESSWIRE / July 15, 2020 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-releas...
Intellipharmaceutics International ( OTC:IPCIF +7.7% ) and Purdue Pharma announce the dismissal of litigation related to patent infringement commenced by Purdue Pharma. More news on: Intellipharmaceutics International Inc., Healthcare stocks news, Read more ...
TORONTO, ON / ACCESSWIRE / July 2, 2020 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-releas...
News, Short Squeeze, Breakout and More Instantly...
Intellipharmaceutics International Inc Company Name:
IPCIF Stock Symbol:
OTCMKTS Market:
Intellipharmaceutics International Inc Website:
TORONTO, ON / ACCESSWIRE / June 14, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI.H) (" Intellipharmaceutics " or the " Company "), announced today that its common stock, currently traded on the OTCQB market, is expected to be downgraded to the OTC Expert Market on J...
MJ Holdings Inc (MJNE) is expected to report for Q1 2024 Meritage Hospitality Group Inc. (MHGU) is expected to report $0.17 for Q1 2024 Fresnillo Plc (FNLPF) is expected to report for Q1 2024 Luna Innovations Incorporated (LUNA) is expected to report $-0.01 for Q1 2024 Cano Health...
TORONTO, ON / ACCESSWIRE / March 13, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) - (" Intellipharmaceutics " or the " Company "), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-rel...